Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegasys in Chronic Hepatitis B with Spontaneous HBV DNA Decline
NCT01892241Phase 3Completed
- Sponsor
- The Third Affiliated Hospital of Sun Yat-sen University
- Start
- Jan 2010
- Primary completion
- Nov 2012
- Modality
- Cytokines & Interferons
01
Overview
Phase 3, open-label trial of interferon alfa in Chronic Hepatitis B (CHB) (3 arms), sponsored by The Third Affiliated Hospital of Sun Yat-sen University. Primary endpoint: Complete viralogic response at 96 weeks. Started Jan 2010; status: completed.
02
Drugs
interferon alfa
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT01892241.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01892241.